Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples

NCT00734045 · clinicaltrials.gov ↗
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Nanogen, Inc.